03/14/2024
3:31 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:04 PM | Regeneron Pharmaceuticals (Issuer)
STAHL NEIL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:04 PM | Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:04 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
3:34 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
2:25 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
3:15 PM | Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/13/2024
4:12 PM | Regeneron Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/09/2024
5:19 PM | Capital World Investors (Filed by)
Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
11:22 AM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/07/2024
4:59 PM | Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
4:07 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
4:06 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
3:05 PM | Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
8:16 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/02/2024
6:16 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
3:47 PM | Regeneron Pharmaceuticals (Subject)
RYAN ARTHUR F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
3:52 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
4:02 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/25/2024
10:10 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
10:11 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Regeneron Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/23/2024
3:17 PM | GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
5:30 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:19 PM | Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:19 PM | LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:20 PM | Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:22 PM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Regeneron Pharmaceuticals (Issuer)
Thompson Craig B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:16 PM | Guarini Kathryn (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:17 PM | Regeneron Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:17 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:06 PM | BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:08 PM | Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:10 PM | POON CHRISTINE A (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
10:31 AM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:28 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:11 PM | Regeneron Pharmaceuticals (Subject)
YANCOPOULOS GEORGE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
3:22 PM | BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
12/26/2023
3:08 PM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
3:22 PM | Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
3:10 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:11 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
10:41 AM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
3:02 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
3:02 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
3:02 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
3:45 PM | Regeneron Pharmaceuticals (Subject)
RYAN ARTHUR F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
6:10 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
6:22 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023
3:48 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2023
3:06 PM | Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
3:02 PM | Regeneron Pharmaceuticals (Subject)
Zoghbi Huda Y (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2023
2:49 PM | Regeneron Pharmaceuticals (Subject)
Tessier-Lavigne Marc (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023
3:05 PM | Decibel Therapeutics, Inc. (Subject)
Regeneron Pharmaceuticals (Filed by)
| Form SC 13D/A | |
09/25/2023
7:48 AM | Decibel Therapeutics, Inc. (Subject)
Regeneron Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
09/12/2023
3:38 PM | Decibel Therapeutics, Inc. (Subject)
Regeneron Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
09/12/2023
3:01 PM | Regeneron Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2023
3:03 PM | Guarini Kathryn (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
3:04 PM | Regeneron Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:14 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2023
6:46 AM | Decibel Therapeutics, Inc. (Subject)
Regeneron Pharmaceuticals (Filed by)
| Form SC TO-T | |
08/24/2023
3:27 PM | Regeneron Pharmaceuticals (Subject)
Van Plew Daniel P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2023
4:06 PM | Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2023
3:52 PM | POON CHRISTINE A (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2023
2:47 PM | Regeneron Pharmaceuticals (Subject)
STAHL NEIL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023
11:27 AM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023
4:16 PM | Decibel Therapeutics, Inc. (Subject)
Regeneron Pharmaceuticals (Filed by)
| Form SC 13D | |
08/10/2023
1:02 PM | Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023
5:56 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
5:48 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2023
1:14 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2023
11:07 AM | Regeneron Pharmaceuticals (Subject)
RYAN ARTHUR F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
3:23 PM | McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023
3:08 PM | MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
6:11 AM | Regeneron Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:14 AM | Regeneron Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
